We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Three Generic-Drug Makers Must Defend Reglan Labeling
Three Generic-Drug Makers Must Defend Reglan Labeling
December 4, 2009
A federal appeals court has reinstated generic-drug makers as defendants in a preemption-related case about liability and labeling of the drug Reglan,
reversing a lower court ruling.